Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Morimoto, Katsuhiko"'
Autor:
Tamaki, Hiroyuki, Eriguchi, Masahiro, Nishimoto, Masatoshi, Uemura, Takayuki, Tasaki, Hikari, Furuyama, Riri, Fukata, Fumihiro, Kosugi, Takaaki, Morimoto, Katsuhiko, Matsui, Masaru, Samejima, Ken-ichi, Tsuruya, Kazuhiko
Publikováno v:
Hypertension Research; Nov2024, Vol. 47 Issue 11, p3246-3254, 9p
Autor:
Fukata, Fumihiro, Eriguchi, Masahiro, Tamaki, Hiroyuki, Uemura, Takayuki, Tasaki, Hikari, Furuyama, Riri, Nishimoto, Masatoshi, Kosugi, Takaaki, Tanabe, Kaori, Morimoto, Katsuhiko, Okamoto, Keisuke, Matsui, Masaru, Samejima, Ken-ichi, Tsuruya, Kazuhiko
Publikováno v:
Clinical & Experimental Nephrology; Apr2024, Vol. 28 Issue 4, p282-292, 11p
Autor:
Uemura, Takayuki, Nishimoto, Masatoshi, Eriguchi, Masahiro, Tamaki, Hiroyuki, Tasaki, Hikari, Furuyama, Riri, Fukata, Fumihiro, Kosugi, Takaaki, Morimoto, Katsuhiko, Matsui, Masaru, Samejima, Ken‐ichi, Tsuruya, Kazuhiko
Publikováno v:
Diabetes, Obesity & Metabolism; Feb2024, Vol. 26 Issue 2, p583-591, 9p
Autor:
Tanabe, Kaori, Samejima, Ken-ichi, Fukata, Fumihiro, Kosugi, Takaaki, Tsushima, Hideo, Morimoto, Katsuhiko, Okamoto, Keisuke, Matsui, Masaru, Eriguchi, Masahiro, Maruyama, Naoki, Akai, Yasuhiro, Tsuruya, Kazuhiko
Publikováno v:
Clinical and experimental nephrology. 26(1):29-35
Background: A dose of 0.5-1 mg/kg/day of prednisolone (PSL) is administered for the initial treatment of minimal change disease (MCD). However, little is known about the optimal PSL dose for the initial treatment of MCD. Methods: We conducted a retro
Autor:
Uemura, Takayuki, Nishimoto, Masatoshi, Eriguchi, Masahiro, Tamaki, Hiroyuki, Tasaki, Hikari, Furuyama, Riri, Fukata, Fumihiro, Kosugi, Takaaki, Morimoto, Katsuhiko, Matsui, Masaru, Samejima, Ken-ichi, Tsuruya, Kazuhiko
Publikováno v:
Hypertension Research; Jun2023, Vol. 46 Issue 6, p1423-1432, 10p
Autor:
Morimoto, Katsuhiko, Matsui, Masaru, Samejima, Ken-ichi, Kanki, Tomoko, Nishimoto, Masatoshi, Tanabe, Kaori, Murashima, Miho, Eriguchi, Masahiro, Akai, Yasuhiro, Iwano, Masayuki, Shiiki, Hideo, Yamada, Hiroharu, Kanauchi, Masao, Dohi, Kazuhiro, Tsuruya, Kazuhiko, Saito, Yoshihiko
Publikováno v:
Diabetic medicine. 37(12):2143-2152
Aims: Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly involve arteries larger than those affected in diabetic nephropathy. However, the associati
Autor:
Tanabe, Kaori, Samejima, Ken-ichi, Fukata, Fumihiro, Kosugi, Takaaki, Tsushima, Hideo, Morimoto, Katsuhiko, Okamoto, Keisuke, Matsui, Masaru, Eriguchi, Masahiro, Maruyama, Naoki, Akai, Yasuhiro, Tsuruya, Kazuhiko
Publikováno v:
Clinical & Experimental Nephrology; Jan2022, Vol. 26 Issue 1, p29-35, 7p
Autor:
Morimoto Katsuhiko
Publikováno v:
Japanese Cultural Studies. :78-98
Autor:
Matsui, Masaru, Takeda, Yukiji, Uemura, Shiro, Matsumoto, Takaki, Seno, Ayako, Onoue, Kenji, Tsushima, Hideo, Morimoto, Katsuhiko, Soeda, Tsunenari, Okayama, Satoshi, Somekawa, Satoshi, Samejima, Ken-ichi, Kawata, Hiroyuki, Kawakami, Rika, Nakatani, Kimihiko, Iwano, Masayuki, Saito, Yoshihiko
Publikováno v:
Kidney international. 85(2):393-403
Patients with chronic kidney disease (CKD) die of cardiovascular diseases for unknown reasons. Blood vessel formation in plaques and its relationship with plaque stability could be involved with signaling through the Flt-1 receptor and its ligands, v
Autor:
Itami, Hiroe, Hara, Shigeo, Samejima, Kenichi, Tsushima, Hideo, Morimoto, Katsuhiko, Okamoto, Keisuke, Kosugi, Takaaki, Kawano, Takahiro, Fujiki, Kengo, Kitada, Hiromichi, Hatakeyama, Kinta, Tsuruya, Kazuhiko, Ohbayashi, Chiho
Publikováno v:
Virchows Archiv: European Journal of Pathology; Oct2020, Vol. 477 Issue 4, p565-572, 8p